- Pharmaceutical Products
- Products By Brand Name
- Products By Dosage Form
- Products By Generic Name
- Products By Therapeutic Class
Find a product
Find Generic
Improvent® HFA Inhaler
Salbutamol + Ipratropium
Description:
Improvent® metered dose inhaler is a combination of Salbutamol and Ipratropium Bromide. Salbutamol is a short acting b2 agonist bronchodilator and Ipratropium Bromide is an anticholinergic bronchodilator. When used in combination, they produce greater bronchodilator effect than either agent alone. Improvent® is expected to maximize the response to treatment in patients with chronic obstructive pulmonary disease (COPD) by reducing bronchospasm through two distinctly different mechanisms, anticholinergic (parasympatholytic) and sympathomimetic. Simultaneous administration of both an anticholinergic (Ipratropium Bromide) and a b2 sympathomimetic (Salbutamol Sulphate) is designed to benefit the patient by producing a greater bronchodilator effect than when either drug is utilised alone at its recommended dosage.
Improvent® metered dose inhaler is a combination of Salbutamol and Ipratropium Bromide. Salbutamol is a short acting b2 agonist bronchodilator and Ipratropium Bromide is an anticholinergic bronchodilator. When used in combination, they produce greater bronchodilator effect than either agent alone. Improvent® is expected to maximize the response to treatment in patients with chronic obstructive pulmonary disease (COPD) by reducing bronchospasm through two distinctly different mechanisms, anticholinergic (parasympatholytic) and sympathomimetic. Simultaneous administration of both an anticholinergic (Ipratropium Bromide) and a b2 sympathomimetic (Salbutamol Sulphate) is designed to benefit the patient by producing a greater bronchodilator effect than when either drug is utilised alone at its recommended dosage.
Indications:
Improvent® inhalation aerosol is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.
Improvent® inhalation aerosol is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.
Content to be added Soon
Different Dosages from Improvent® HFA Inhaler
-
- 100 mcg & 20 mcg
- Price : Tk 250
-
- 100 mcg & 20 mcg
- Price : Tk 250
Other Brands From Same Therapeutic Class
